Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vicent M. Guillem, Cristina Arbona, Juan Carlos Hernández-Boluda, María José Terol, Rosa Goterris, Carlos Solano & Mar Tormo. (2011) An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant. Leukemia & Lymphoma 52:7, pages 1249-1254.
Read now
Read now
Articles from other publishers (28)
. 2020. Cancer Biology and Advances in Treatment. Cancer Biology and Advances in Treatment
157
169
.
Gro Elise Rødland, Katrine Melhus, Roman Generalov, Sania Gilani, Francesco Bertoni, Jostein Dahle, Randi G. Syljuåsen & Sebastian Patzke. (2019) The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines. Frontiers in Oncology 9.
Crossref
Crossref
Christine Roussel, Kristine L. Witt, Peter B. Shaw & Thomas H. Connor. (2019) Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs. Mutation Research/Reviews in Mutation Research 781, pages 207-217.
Crossref
Crossref
Joy Tang, Nan Zhu, Sridhar Rao & Karen-Sue Carlson. (2019) Stem cell damage after chemotherapy- can we do better?. Best Practice & Research Clinical Haematology 32:1, pages 31-39.
Crossref
Crossref
Maria Cabezas, Lydia García-Quevedo, Cintia Alonso, Marta Manubens, Yolanda Álvarez, Joan Francesc Barquinero, Santiago Ramón y Cajal, Margarita Ortega, Adoración Blanco, María Rosa Caballín & Gemma Armengol. (2019) Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms. Scientific Reports 9:1.
Crossref
Crossref
Shweta Lawania, Navneet Singh, Digamber Behera & Siddharth Sharma. (2017) XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes. Pathology & Oncology Research 24:2, pages 353-366.
Crossref
Crossref
Sandrine Lacoste, Smita Bhatia, Yanjun Chen, Ravi Bhatia & Timothy R. O’Connor. (2017) Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes. PLOS ONE 12:2, pages e0171473.
Crossref
Crossref
Carlos E. Bueso-Ramos, Rashmi Kanagal-Shamanna, Mark J. Routbort & Curtis A. Hanson. (2015) Therapy-Related Myeloid Neoplasms. American Journal of Clinical Pathology 144:2, pages 207-218.
Crossref
Crossref
Simon B. Zeichner & Martha L. Arellano. (2015) Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process. Current Treatment Options in Oncology 16:8.
Crossref
Crossref
Todd M. Gibson & Leslie L. Robison. (2014) Impact of Cancer Therapy-Related Exposures on Late Mortality in Childhood Cancer Survivors. Chemical Research in Toxicology 28:1, pages 31-37.
Crossref
Crossref
Ting Zhou, Peishuai Chen, Jian Gu, Alexander Bishop, Linda Scott, Paul Hasty & Vivienne Rebel. (2015) Potential Relationship between Inadequate Response to DNA Damage and Development of Myelodysplastic Syndrome. International Journal of Molecular Sciences 16:1, pages 966-989.
Crossref
Crossref
David A. Eastmond, Nagalakshmi Keshava & Babasaheb Sonawane. (2014) Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview. Mutation Research/Reviews in Mutation Research 761, pages 40-64.
Crossref
Crossref
M A Jacoby, R E De Jesus Pizarro, J Shao, D C Koboldt, R S Fulton, G Zhou, R K Wilson & M J Walter. (2013) The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia. Leukemia 28:6, pages 1242-1251.
Crossref
Crossref
Hongyan Cheng, Qin Qin, Xinchen Sun, Fan Li, Ning Sun, Lu Cheng, Zuhong Lu & Baoan Chen. (2013) Predictive Effect of XPA and XPD Polymorphisms on Survival of Advanced NSCLC Patients Treated with Platinum-Based Chemotherapy: A Three-Dimensional (3-D), Polyacrylamide Gel-Based DNA Microarray Method. Technology in Cancer Research & Treatment 12:5, pages 473-482.
Crossref
Crossref
Xiaomeng Xie, Chunhua Zhang, Minfeng Liu, Guangyu Yao, Lin Tong, Jun Chen, Chuanqiang Huang, Zhaoze Guo & Changsheng Ye. (2013)
Successful Chemotherapy for a Case of Therapy-Related ALL with
MLL
Gene Rearrangement Following Treatment of Breast Cancer
. The Breast Journal 19:4, pages 451-452.
Crossref
Crossref
Nada Suvajdžić, Zorica Cvetković, Vesna Đorđević, Nada Kraguljac-Kurtović, Dejana Stanisavljević, Andrija Bogdanović, Irena Đjunić, Nataša Čolović, Ana Vidović, Ivo Elezović & Dragica Tomin. (2012) Prognostic factors for therapy-related acute myeloid leukaemia (t-AML) – A single centre experience. Biomedicine & Pharmacotherapy 66:4, pages 285-292.
Crossref
Crossref
Agnieszka Vay, Sanjeev Kumar, Shelly Seward, Assaad Semaan, Charles A. Schiffer, Adnan R. Munkarah & Robert T. Morris. (2011) Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis. Gynecologic Oncology 123:3, pages 456-460.
Crossref
Crossref
Ravi Bhatia & H Joachim Deeg. (2011) Treatment-related myelodysplastic syndrome: molecular characteristics and therapy. Current Opinion in Hematology 18:2, pages 77-82.
Crossref
Crossref
Stephen K. Gruschkus, David Lairson, J. Kay Dunn, Jan Risser & Xianglin L. Du. (2010) Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non‐Hodgkin lymphoma. Cancer 116:22, pages 5279-5289.
Crossref
Crossref
Vicent M. Guillem, Francisco Cervantes, Jesús Martínez, Alberto Alvarez‐Larrán, María Collado, Mireia Camós, Anna Sureda, Margherita Maffioli, Isabel Marugán & Juan‐Carlos Hernández‐Boluda. (2010)
XPC
genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia
. American Journal of Hematology 85:7, pages 482-486.
Crossref
Crossref
Giuseppe Leone, Luana Fianchi, Livio Pagano & Maria Teresa Voso. (2010) Incidence and susceptibility to therapy-related myeloid neoplasms. Chemico-Biological Interactions 184:1-2, pages 39-45.
Crossref
Crossref
Hyoeun ShimHyun-Sook ChiSeongsoo JangEul-Ju SeoChan-Jeoung ParkJung-Hee LeeJe-Hwan LeeKyoo-Hyung Lee. (2010) Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor. The Korean Journal of Hematology 45:3, pages 177.
Crossref
Crossref
Heath D. Worcester & Mohammad A. Vasef. (2011) Therapy-Related Acute Myeloid Leukemia with 11q23 Abnormality Coexisting with Refractory Metastatic Ewing Sarcoma: Report of a Case and Review of the Literature. Pediatric and Developmental Pathology 13:1, pages 50-54.
Crossref
Crossref
Carlos E. Bueso-Ramos. 2010. Neoplastic Hematopathology. Neoplastic Hematopathology
145
163
.
Sergej N. Konoplev & Carlos E. Bueso-Ramos. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
463
471
.
Danny Robson & Sunil Verma. (2009) Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?. The Oncologist 14:10, pages 950-958.
Crossref
Crossref
Pearlie K Epling-Burnette & Alan F List. (2009) Advancements in the molecular pathogenesis of myelodysplastic syndrome. Current Opinion in Hematology 16:2, pages 70-76.
Crossref
Crossref
Anthony J. Berdis. (2008) DNA Polymerases as Therapeutic Targets. Biochemistry 47:32, pages 8253-8260.
Crossref
Crossref